Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 05
2025
|
Guy P Sansone Director |
BUY
Open market or private purchase
|
Direct |
1,570
+11.56%
|
$98,910
$63.7 P/Share
|
|
May 31
2025
|
Brian Newman EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,861
+50.0%
|
$1,399,104
$64.04 P/Share
|
|
May 31
2025
|
Amy Compton Phillips EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,091
+30.26%
|
$3,397,824
$64.04 P/Share
|
|
May 15
2025
|
Guy P Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+16.6%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
Douglas H. Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+32.69%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,769
+19.63%
|
$166,140
$60.47 P/Share
|
|
May 15
2025
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
144
+2.22%
|
$8,640
$60.47 P/Share
|
|
May 15
2025
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,077
+32.69%
|
$124,620
$60.47 P/Share
|
|
May 15
2025
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+15.81%
|
$133,920
$60.47 P/Share
|
|
May 15
2025
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,232
+1.74%
|
$133,920
$60.47 P/Share
|
|
May 15
2025
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
692
+50.0%
|
$41,520
$60.47 P/Share
|
|
May 15
2025
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,263
+5.46%
|
$135,780
$60.47 P/Share
|
|
May 06
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
150,000
-1.8%
|
$9,900,000
$66.67 P/Share
|
|
May 05
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
1,323,932
-6.92%
|
$88,703,444
$67.68 P/Share
|
|
May 02
2025
|
Larry Robbins Director |
SELL
Open market or private sale
|
Indirect |
2,276,068
-6.65%
|
$154,772,624
$68.48 P/Share
|
|
Apr 01
2025
|
Prem S Shah EVP and Group President |
BUY
Grant, award, or other acquisition
|
Direct |
26,478
+31.28%
|
$1,774,026
$67.98 P/Share
|
|
Apr 01
2025
|
Prem S Shah EVP and Group President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-2.69%
|
$87,636
$67.98 P/Share
|
|
Apr 01
2025
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,847
-3.43%
|
$123,749
$67.98 P/Share
|
|
Apr 01
2025
|
Samrat S. Khichi EVP, CPO and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
16,181
+28.02%
|
$1,084,127
$67.98 P/Share
|
|
Apr 01
2025
|
Samrat S. Khichi EVP, CPO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-6.66%
|
$103,716
$67.98 P/Share
|
|
Apr 01
2025
|
Tilak Mandadi EVP, Chief Experience & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
20,594
+15.05%
|
$1,379,798
$67.98 P/Share
|
|
Apr 01
2025
|
Tilak Mandadi EVP, Chief Experience & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
995
-2.24%
|
$66,665
$67.98 P/Share
|
|
Apr 01
2025
|
Steven H Nelson EVP and President, Aetna |
BUY
Grant, award, or other acquisition
|
Direct |
21,329
+50.0%
|
$1,429,043
$67.98 P/Share
|
|
Apr 01
2025
|
Heidi B Capozzi EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,768
+10.99%
|
$788,456
$67.98 P/Share
|
|
Apr 01
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,710
+37.32%
|
$985,570
$67.98 P/Share
|
|
Apr 01
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,266
-16.78%
|
$151,822
$67.98 P/Share
|
|
Apr 01
2025
|
Thomas F. Cowhey EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
16,181
+28.24%
|
$1,084,127
$67.98 P/Share
|
|
Apr 01
2025
|
Thomas F. Cowhey EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,203
-6.0%
|
$214,601
$67.98 P/Share
|
|
Mar 17
2025
|
Prem S Shah EVP and Group President |
BUY
Exercise of conversion of derivative security
|
Direct |
846
+1.92%
|
$52,452
$62.21 P/Share
|
|
Mar 05
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Open market or private sale
|
Direct |
7,513
-47.23%
|
$495,858
$66.35 P/Share
|
|
Mar 05
2025
|
James David Clark SVP, Cont & Chief Acct Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,513
+32.08%
|
$465,806
$62.21 P/Share
|
|
Feb 28
2025
|
Thomas F. Cowhey EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,318
-10.52%
|
$345,670
$65.72 P/Share
|
|
Feb 28
2025
|
J. David Joyner President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,944
-4.0%
|
$126,360
$65.72 P/Share
|
|
Feb 28
2025
|
Samrat S. Khichi EVP, CPO and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,604
-21.8%
|
$364,260
$65.72 P/Share
|
|
Feb 18
2025
|
Michael F Mahoney Director |
BUY
Open market or private purchase
|
Direct |
30,000
+43.26%
|
$1,980,000
$66.7 P/Share
|
|
Dec 05
2024
|
Anne A. Finucane Director |
SELL
Bona fide gift
|
Direct |
2,665
-36.85%
|
$149,240
$56.86 P/Share
|
|
Nov 30
2024
|
James David Clark SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
86
-1.01%
|
$5,074
$59.85 P/Share
|
|
Nov 30
2024
|
Heidi B Capozzi EVP and Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,542
+50.0%
|
$4,928,978
$59.85 P/Share
|
|
Nov 30
2024
|
Roger N Farah Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,125
+50.0%
|
$2,957,375
$59.85 P/Share
|
|
Nov 30
2024
|
Tilak Mandadi EVP, Chief Experience & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
50,125
+33.45%
|
$2,957,375
$59.85 P/Share
|
|
Nov 21
2024
|
Guy P Sansone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+20.83%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Douglas H. Shulman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+50.0%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Leslie V Norwalk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+50.0%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+32.77%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,331
+6.39%
|
$132,867
$57.1 P/Share
|
|
Nov 21
2024
|
J Scott Kirby Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,933
+25.51%
|
$167,181
$57.1 P/Share
|
|
Nov 21
2024
|
Michael F Mahoney Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,200
+26.19%
|
$125,400
$57.1 P/Share
|
|
Nov 21
2024
|
Fernando Aguirre Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+6.02%
|
$134,748
$57.1 P/Share
|
|
Nov 21
2024
|
Jeffrey R. Balser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,375
+19.75%
|
$135,375
$57.1 P/Share
|
|
Nov 21
2024
|
C David Brown Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,331
+1.85%
|
$132,867
$57.1 P/Share
|